Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors

Details for Australian Patent Application No. 2005212405 (hide)

Owner Bristol-Myers Squibb Company

Inventors Chidambaram, Ramakrishnan; Chen, Bang-Chi; Lajeunesse, Jean; Galella, Michael; Dimarco, John D.; Droghini, Roberto

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005212405

PCT Pub. Number WO2005/077945

Priority 60/624,937 04.11.04 US; 60/542,490 06.02.04 US

Filing date 4 February 2005

Wipo publication date 25 August 2005

Acceptance publication date 12 August 2010

International Classifications

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07C 235/28 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 237/42 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07D 277/56 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/077945 Priority application(s): WO2005/077945

12 August 2010 Application Accepted

  Published as AU-B-2005212405

9 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005212409-Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors

2005212401-Method of prognosis of metastasis by detection of FRA12E fragile site within the SMRT gene/locus at chromosome 12q24